Episode

Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis

Podcast

The IMID Forum

Published

Nov 13, 2025

Duration seconds

877

Processing state

not_requested

Canonical source

https://soundcloud.com/imidforum/discussing-axspa-adalimumab-dosing-and-uveitis-recurrence-in-patients-with-ankylosing-spondylitis

Audio

https://feeds.soundcloud.com/stream/2211731435-imidforum-discussing-axspa-adalimumab-dosing-and-uveitis-recurrence-in-patients-with-ankylosing-spondylitis.mp3

JSON

/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-adalimumab-dosing-and-uveitis-recurrence-in-patients-with-ankylosing-spondylitis

Markdown

/podcast/the-imid-forum-981476/discussing-axspa-adalimumab-dosing-and-uveitis-recurrence-in-patients-with-ankylosing-spondylitis.md

Actions

• POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-adalimumab-dosing-and-uveitis-recurrence-in-patients-with-ankylosing-spondylitis/transcription-requests
  Idempotently request low-priority transcript generation for this episode.
• GET https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-adalimumab-dosing-and-uveitis-recurrence-in-patients-with-ankylosing-spondylitis.md
  Read the agent-friendly Markdown representation of this episode resource.

Summary

Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered the Association between adalimumab dosing interval and uveitis recurrence in patients with ankylosing spondylitis.